ClinicalTrials.gg
Sign In

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Sichuan Biokin Pharmaceutical Co., Ltd. clinical trials

Also known as Baili.

The registry lists 149 studies whose lead sponsor is Sichuan Biokin Pharmaceutical Co., Ltd. or one of 2 companies grouped under it. 104 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 23, 2026.

Keep track of what changes. Save the Sichuan Biokin Pharmaceutical Co., Ltd. studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

Status

Recruiting
84
Active, not recruiting
38
Not yet recruiting
20
Terminated
3
Status unknown
2
Withdrawn
1

Phase

Phase 1
73
Phase 2
64
Phase 3
37
Phase 4
1

Where

China
140
United States
9
Italy
2
Spain
2
France
2
Serbia
1

Registry sponsor names on this page

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Sichuan Biokin Pharmaceutical Co., Ltd..

  • Sichuan Baili Pharmaceutical Co., Ltd.
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    140 studies →
  • SystImmune Inc.
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    9 studies →

Focus areas

Conditions Sichuan Biokin Pharmaceutical Co., Ltd. leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Carcinoma, Non-Small-Cell Lung24Breast Neoplasms15Squamous Cell Carcinoma of Head and Neck12

Studies

Recruiting first, then most recently updated. Showing 50 of 149. Browse all 149 →